WesBanco Bank’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.9M Buy
68,209
+8,021
+13% +$1.51M 0.32% 76
2026
Q1
$11.9M Sell
60,188
-2,593
-4% -$500K 0.33% 76
2025
Q4
$11.5M Sell
62,781
-1,739
-3% -$305K 0.32% 75
2025
Q3
$9.9M Buy
64,520
+2,697
+4% +$408K 0.28% 87
2025
Q2
$8.64M Buy
61,823
+6,534
+12% +$916K 0.26% 90
2025
Q1
$8.13M Buy
55,289
+2,728
+5% +$395K 0.28% 85
2024
Q4
$6.89M Buy
52,561
+13,195
+34% +$1.85M 0.24% 93
2024
Q3
$6.13M Buy
39,366
+2,616
+7% +$422K 0.21% 105
2024
Q2
$5.73M Sell
36,750
-242
-0.7% -$36.4K 0.21% 105
2024
Q1
$5.01M Buy
+36,992
New +$4.9M 0.19% 118
2021
Q4
Sell
-3,460
Closed -$416K 584
2021
Q3
$416K Buy
3,460
+183
+6% +$21.3K 0.02% 442
2021
Q2
$393K Hold
3,277
0.01% 448
2021
Q1
$326K Buy
+3,277
New +$329K 0.01% 461

Other funds holding AZN

WesBanco Bank's AZN Position: Q2 2026 in Review

WesBanco Bank increased its AstraZeneca (AZN) stake by 13% in Q2 2026, buying an estimated $1.51M and bringing the position to 68,209 shares worth $12.9M. The position accounts for 0.32% of the portfolio, ranked #76.

WesBanco Bank first reported a position in AZN in Q1 2021 and has held it in 13 quarters since. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • WesBanco Bank held 68,209 shares of AstraZeneca worth $12.9M as of Q2 2026.
  • WesBanco Bank bought 8,021 AstraZeneca shares in Q2 2026, an estimated $1.51M.
  • AstraZeneca made up 0.32% of WesBanco Bank's portfolio in Q2 2026, its #76 holding.
  • WesBanco Bank first reported a position in AstraZeneca in Q1 2021 and has held it in 13 quarters since.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on WesBanco Bank's 13F filing for Q2 2026, filed 28 Jul 2026.